Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Intangibles: 2012-2020

Historic Intangibles for Capricor Therapeutics (CAPR) over the last 9 years, with Dec 2020 value amounting to $2,165.

  • Capricor Therapeutics' Intangibles fell 79.99% to $1,083 in Q1 2021 from the same period last year, while for Mar 2021 it was $1,083, marking a year-over-year decrease of 79.99%. This contributed to the annual value of $2,165 for FY2020, which is 66.67% down from last year.
  • Per Capricor Therapeutics' latest filing, its Intangibles stood at $2,165 for FY2020, which was down 66.67% from $6,495 recorded in FY2019.
  • In the past 5 years, Capricor Therapeutics' Intangibles ranged from a high of $142,253 in FY2016 and a low of $2,165 during FY2020.
  • Over the past 3 years, Capricor Therapeutics' median Intangibles value was $6,495 (recorded in 2019), while the average stood at $19,477.
  • Data for Capricor Therapeutics' Intangibles shows a maximum YoY slumped of 90.52% (in 2016) over the last 5 years.
  • Yearly analysis of 5 years shows Capricor Therapeutics' Intangibles stood at $142,253 in 2016, then crashed by 34.59% to $93,048 in 2017, then slumped by 46.51% to $49,772 in 2018, then crashed by 86.95% to $6,495 in 2019, then slumped by 66.67% to $2,165 in 2020.